Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06843213 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention

Study acronym: THRIVE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 33% 390 → 262 participants
See other at-risk trials from University of Pennsylvania

Record History

  1. Enrollment reduced: 390 → 262 participants Eligibility criteria expanded, about 8 words · Publications: details revised at 47 of 47 entries Show 2 more changesShow less
    • Eligibility criteria expanded, about 8 words
    • Publications: details revised at 47 of 47 entries
  2. Study title revisedv3 See this version in full on ClinicalTrials.gov ↗
  3. Primary completion date: Aug 2027 to Apr 1, 2028 Completion date: Dec 2028 to Aug 1, 2028v2 Show 1 more changeShow less
    • Completion date: Dec 2028 to Aug 1, 2028
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to develop an acceptable, feasible, and effective peer-led bundle of health resilience and promotion services to be delivered in the hospital setting, called the THRIVE intervention. The main question it aims to answer is: Will participants receiving the THRIVE intervention have a reduced risk of self-reported non-fatal overdoses OR skin/soft tissue infections compared to participants receiving enhanced usual care? Researchers will compare the THRIVE model to enhanced usual care to see if the THRIVE model helps participants reduce their number of self-reported non-fatal overdoses OR skin/soft tissue infections. Intervention participants will: * Receive one in-person session from a peer support specialist while in the hospital * Receive weekly text messages from the peer support specialist for a 12-week period * Receive monthly, multiple-choice assessments via text message at Month 1, 2, 3, 4, 5, and 6 * Complete a baseline, 3-month, and 6-month assessment with Research Assistants Enhanced usual care participants will: * Receive a handout with health resilience education and resources in their local area * Receive monthly, multiple-choice assessments via text message at Month 1, 2, 3, 4, 5, and 6 * Complete a baseline, 3-month, and 6-month assessment with Research Assistants
Trial Details
NCT Number NCT06843213
Lead Sponsor University of Pennsylvania
Collaborators: National Institute on Drug Abuse (NIDA), University of Pittsburgh
Conditions Opioid Use Disorder, Harm Reduction, Health Promotion
Enrollment 262 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov